Peter Bui
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Pharmacogenetics and Drug Metabolism 7
-
- Eicosanoids and Hypertension Pharmacology 4
- Co-authors
- Oliver HankinsonSudheer BeedanagariErin L. HsuDerek W. NickersonSatoshi ImaizumiFeng WangSrinivasa T. ReddyRobert T. Taylor
- Journals
- Molecular Pharmacology (3 papers)Drug Metabolism and Disposition (2 papers)Toxicological Sciences (1 paper)BMC Microbiology (1 paper)Molecular Cytogenetics (1 paper)
- Partner nations
- United StatesJapanVietnam
In The Last Decade
Peter Bui
15 papers receiving 505 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 142
- Biochemistry 76
- Geriatrics and Gerontology 25
- Cancer Research 89
- Oncology 118
Countries citing papers authored by Peter Bui
This map shows the geographic impact of Peter Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bui more than expected).
Fields of papers citing papers by Peter Bui
This network shows the impact of papers produced by Peter Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bui. The network helps show where Peter Bui may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Bui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | Continuous Vasopressin Infusion for the Management of Central Diabetes Insipidus | 2017 | 2 |
| 4 | 2013 | 1 | |
| 5 | PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity. | 2013 | 88 |
| 6 | 2013 | 15 | |
| 7 | 2011 | 35 | |
| 8 | 2011 | 15 | |
| 9 | 2011 | 9 | |
| 10 | 2010 | 68 | |
| 11 | 2010 | 54 | |
| 12 | 2009 | 110 | |
| 13 | 2009 | 40 | |
| 14 | 2009 | 39 | |
| 15 | 2008 | 25 |
About Peter Bui
Peter Bui is a scholar working on Pharmacology, Biochemistry, Geriatrics and Gerontology, Cancer Research and Small Animals, having authored 15 papers that have together received 507 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Carcinogens and Genotoxicity Assessment (2 papers), Glutathione Transferases and Polymorphisms (2 papers), Genomic variations and chromosomal abnormalities (2 papers), Glycogen Storage Diseases and Myoclonus (1 paper), Advanced Breast Cancer Therapies (1 paper) and Genomics, phytochemicals, and oxidative stress (1 paper). The work is most often cited by research in Pharmacology (142 citations), Biochemistry (76 citations), Geriatrics and Gerontology (25 citations), Cancer Research (89 citations) and Oncology (118 citations). Peter Bui has collaborated with scholars based in United States, Japan and Vietnam. Frequent co-authors include Oliver Hankinson, Sudheer Beedanagari, Erin L. Hsu, Derek W. Nickerson, Satoshi Imaizumi, Feng Wang, Srinivasa T. Reddy, Robert T. Taylor, Parrisa Solaimani and Xiao‐Meng Wu. Their work appears in journals such as Molecular Pharmacology, Drug Metabolism and Disposition, Toxicological Sciences, BMC Microbiology and Molecular Cytogenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.